Breaking News
FONT-SIZE Plus   Neg
Share SHARE

WSJ: NYSE CEO Says Will Not Sell Euronext To Rival Browse

New York Stock Exchange parent NYSE Euronext, Inc. (NYX: Quote) does not intend to sell Euronext to a rival as part of its proposed acquisition by IntercontinentalExchange, Inc. (ICE: Quote), NYSE Euronext CEO Duncan Niederauer said, according to the Wall Street Journal on Wednesday.

Meanwhile, Niederauer reportedly added that the combined entity will instead spinoff Euronext through an initial public offer. The spinoff was agreed as part of the proposed $8.2 billion acquisition of NYSE Euronext by ICE in order to allay potential antitrust concerns.

The news that Euronext would be spunoff had sparked buying interests from rival browse operators, such as Nasdaq OMX Group, Inc. (NDAQ) and London Stock Exchange Group Plc (LSE.L). However, Niederauer has now cleared the air, and reportedly said that he plans to have Euronext listed separately.

ICE agreed in mid-December to acquire NYSE Euronext in cash and cash deal valued at about $8.2 billion, and planned an initial public offering of Euronext as a Continental European-based entity following the closure of the deal, if market conditions and European policy makers support the offering. The deal is expected to close in the second half of 2013, subject to shareholder and regulatory approvals.

The proposed deal will give ICE access to the NYSE Liffe derivatives market in London, providing the exchange operator with an entry point to fixed-income futures.

New York-based NYSE Euronext is the operator of the NYSE, NYSE Arca, Inc., and NYSE Amex LLC in the U.S., and five Europe-based exchanges that comprise Euronext N.V.

Meanwhile, Atlanta, Georgia-based ICE operates regulated exchanges, clearing houses, and over-the-counter or OTC markets for agricultural, credit, currency, emissions, energy, and equity index contracts.

The proposed merger comes nearly two years after ICE and Nasdaq OMX Group launched a joint hostile $11.3 billion bid for the Big Board. However, the two companies were forced to retreat in May 2011 after their takeover plan was opposed by U.S. antitrust officials.

Meanwhile, NYSE Euronext plans to merge with Germany Stock Exchange Deutsche Boerse AG (DBOEF.PK, DBOEY.PK) was also scuttled by European Union regulators in February 2012. The two exchanges mutually agreed to terminate their merger deal that was agreed upon in February 2011.

Prior to that, London Stock Exchange in February 2011 agreed to combine with Toronto-based TMX Group, Inc. (X.TO, TSX_X.TO), and in October 2010, Singapore Exchange Ltd. agreed to buy Australia-based ASX Ltd. for about A$8.4 billion. Both the deals failed to materialize.

NYX closed Wednesday's regular trading session at $33.35, down $0.10 or 0.30% on a volume of 5.98 million shares.

Register
To receive FREE breaking news email alerts for NYSE Euronext and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.